NFKB1 and lung disorder: Previous studies of myocardial ischemia indicate that ox-CaMKII enhances NF-κB-mediated inflammatory signaling in cardiomyocytes and is closely associated with the development of cardiovascular and pulmonary diseases and cancer [7, 48].